Article Text

Download PDFPDF
The FIFA/F-MARC update on doping
  1. J Dvorak1,
  2. P McCrory2,
  3. M D’Hooghe3,
  4. M Saugy4
  1. 1FIFA Chief Medical Officer, FIFA Medical Assessment and Research Centre, and Department of Neurology, Schulthess Clinic, Zurich, Switzerland
  2. 2Centre for Health, Exercise and Sports Medicine, University of Melbourne, Australia
  3. 3FIFA Sports Medical Committee, FIFA Executive Committee, Bruges, Belgiun
  4. 4Swiss Laboratory for Doping Analyses, Institute of Legal Medicine, Lausanne, Switzerland
  1. Correspondence to:
 Professor J Dvorak
 Chairman, FIFA Medical Assessment and Research Centre, Department of Neurology, Schulthess Clinic, Lengghalde 2, 8008 Zurich, Switzerland; jiri.dvorak{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The ongoing media debate surrounding the issue of doping in sport has raised public awareness of a problem that been steadily developing over many years. This controversy reflects both the rapid development of various sports disciplines as well as the evolution of new doping methods and agents.

The Fédération Internationale de Football Association (FIFA) introduced doping controls in football in 1970 to ensure that the results of national and international matches were a fair reflection of the ability of those taking part. Over the past 12 years, the FIFA Medical Assessment and Research Centre (F-MARC) has developed a worldwide network of specialists who are involved in the educational process within the regional football confederations and national associations as one facet of global anti-doping strategies. F-MARC has also been involved in the practical implementation of doping controls for FIFA competitions at all levels. FIFA has developed close collaboration …

View Full Text